Phenactropinium

Phenactropinium

SCHEMBL8916468

C[N+]1(CC(=O)c2ccccc2)C2CCC1CC(OC(=O)C(O)c1ccccc1)C2

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 5/20 0.70
CHRM1 P11229 4/20 0.70
CHRNA7 P36544 2/20 0.59
CHRM3 P20309 4/20 0.56
LMNA P02545 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
HSD17B10 Q99714 1/20 0.55
CHRM4 P08173 3/20 0.54
CHRM5 P08912 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
BLM P54132 2/20 0.54
PABPC1 P11940 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
CYP2C19 P33261 1/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
TSHR P16473 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenactropinium SCHEMBL29387827 1.00 CHRM2 (0.70) CHRM2CHRM1CHRNA7CHRM3LMNA
Phenactropinium SCHEMBL308786 0.99 CHRM2 (0.69) CHRM2CHRM1CHRNA7CHRM3LMNA
Methylhomatropine SCHEMBL17179980 0.83 CHRM2 (1.00) CHRM2CHRM1CHRM3LMNACYP2D6
Methylhomatropine SCHEMBL16784195 0.83 CHRM2 (1.00) CHRM2CHRM1CHRM3LMNACYP2D6
Methylhomatropine SCHEMBL30516140 0.83 CHRM2 (1.00) CHRM2CHRM1CHRM3LMNACYP2D6
Methylhomatropine SCHEMBL77827 0.82 CHRM2 (0.97) CHRM2CHRM1CHRM3LMNACYP2D6
Methylhomatropine SCHEMBL29555824 0.82 CHRM2 (0.97) CHRM2CHRM1CHRM3LMNACYP2D6
Methylhomatropine SCHEMBL20659943 0.82 CHRM2 (0.97) CHRM2CHRM1CHRM3LMNACYP2D6
Methylhomatropine SCHEMBL613580 0.82 CHRM2 (0.97) CHRM2CHRM1CHRM3LMNACYP2D6
Fentonium SCHEMBL251444 0.81 CHRM2 (0.68) CHRM2CHRM1CHRM3LMNACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5686448-A Treatment of virus infections with ganglionic blocking agents BALTECH, INC. (US) 1997-11-11 US disclosed
US-4902720-A Treatment of virus infections with quaternary ammonium compounds BALTECH, INC., A CORP. OF LA 1990-02-20 US disclosed
US-4898888-A SUCH AS TETRAETHYLAMMONIUM OR HEXAMETHONIUM ION; HERPES SIMPLEX BALTECH, INC. 1990-02-06 US disclosed